Amgen's Tezepelumab Reduces Exacerbations In Patients With Severe Asthma & Comorbid Nasal Polyps
5/9 16:56
(RTTNews) - Amgen (AMGN) said new data from the pivotal NAVIGATOR Phase 3 trial demonstrated that tezepelumab reduced exacerbations and improved lung function and nasal symptoms in patients with severe, uncontrolled asthma and comorbid nasal polyps....